siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide. [electronic resource]
Producer: 20110310Description: 453-60 p. digitalISSN:- 1523-1747
- Antineoplastic Agents, Alkylating -- pharmacology
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Dacarbazine -- analogs & derivatives
- G1 Phase -- drug effects
- Gene Silencing -- drug effects
- Humans
- Melanoma -- metabolism
- RNA, Small Interfering -- pharmacology
- Ribonucleoside Diphosphate Reductase -- genetics
- S Phase -- drug effects
- Skin Neoplasms -- metabolism
- Temozolomide
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.